Explore India’s historic Supreme Court ruling on passive euthanasia in the case of Harish Rana, a man in a vegetative state for 13 years. This landmark decision allows withdrawal of life support, affirming the right to die with dignity under Article 21. Delve into the legal evolution, family struggles, court directives, and public reactions. A compassionate step forward in end-of-life care debates
An incident at Ummed Hospital in Jodhpur where resident doctors and nursing staff reportedly played Holi inside the labour room has led to disciplinary action. The inquiry committee found involvement of 14 resident doctors and nursing officers. The incident also raises concerns about hospital hygiene, professional conduct, and safety in sensitive clinical areas.
Maharashtra’s Health Department is cancelling licences of 34 doctors for PCPNDT Act violations, intensifying the fight against sex determination and female foeticide. Enacted in 1994, the Act bans fetal sex disclosure to curb skewed sex ratios. This action, announced March 7, 2026, follows assembly concerns and targets improper records and equipment
Dr. Mari Basar, Arunachal Pradesh’s trailblazing oncologist, passed away at 67 on March 5, 2026. From humble beginnings in Nyigam village to earning his MBBS and MS at RIMS, Imphal, he became the state’s first dedicated cancer surgeon after training at Tata Memorial Hospital. His pivotal role in developing oncology at TRIHMS brought hope to many. Remembered for compassion and dedication, his legac
Himachal Pradesh leaps forward in healthcare as CM Sukhvinder Singh Sukhu launches robotic surgery at Nerchowk Medical College on March 6, 2026. At ₹28.44 crore, it’s the third state facility, offering precise, minimally invasive ops for faster recovery in remote areas. Plans to expand statewide, boosting equity and outcomes.
NMC’s March 2026 notice mandates Foreign Medical Graduates (FMGs) extend study periods for physical compensation of online MBBS classes. No shortcuts allowed; detailed certificates required. Affects FMGs from abroad amid COVID disruptions. Ensures quality equivalence to Indian standards. Key: Extended timelines, verified docs, India internships post-2021. Vital for aspiring doctors.
Medico-legal landscape of euthanasia in India, focusing on passive euthanasia and advance directives (living wills). From landmark Supreme Court rulings like Aruna Shanbaug (2011) and Common Cause (2018 & 2023) to patient autonomy and ethical considerations in end-of-life care.
Explore the debate on transparency in India’s medical education. With surging MBBS and PG seats, questions arise over NMC’s annual assessment reports. Minister Anupriya Patel addresses concerns in Lok Sabha, highlighting disclosures and legal hurdles. Discover why full reports matter for students and healthcare quality, and tips for informed choices.
The halted indefinite hunger strike by Tamil Nadu government doctors on March 5, 2026, over pay, promotions, and working conditions. Police intervention ended the protest at Rajiv Gandhi Government General Hospital, highlighting ongoing grievances in public healthcare. Learn about FOGDA’s demands, the event’s unfolding, and broader implications for the system.
In a shocking verdict from Puducherry, 61-year-old farmer R Sivapoosanam receives a 5-year prison sentence for forging documents to secure MBBS seats for his children under the local quota. After a grueling 22-year trial, this case exposes the fierce competition in India’s medical admissions, judicial inefficiencies, and ethical pitfalls in education. It calls for reforms like better verification
Cipla USA has recalled over 400 cartons of Nilotinib, a generic anti-cancer drug for CML, due to minor manufacturing specs issues. This Class III recall poses no health risks but highlights quality controls in pharma. Explore implications for patients, Cipla’s stock, and the Indian generics industry in this detailed breakdown. Stay informed on USFDA updates for global drug safety.
Explore Gland Pharma’s ₹6.29 crore GST dispute from Telangana authorities over export reclassifications and credit notes for FY 2019-20. The company deems it unjustified and plans an appeal, assuring no major impact. Dive into company overview, market reactions, stock performance, and broader pharma sector implications as of March 9, 2026. Solid fundamentals persist amid short-term volatility.
